Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 13 Glioblastoma 10 Glioma 7 Astrocytoma 6 Carcinoma, Non-Small-Cell Lung 5 Urinary Bladder Neoplasms 4 Neoplasms 4 Brain Neoplasms 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Stomach Neoplasms 2 Recurrence 2 Pancreatic Neoplasms 2 Oligodendroglioma 2 Melanoma 2 Carcinoma 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Diseases 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Seroma 1 Rectal Neoplasms 1 Pleural Neoplasms 1 Pleural Effusion, Malignant 1 Pleural Effusion 1 Pleural Diseases 1 Patient Preference 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Inflammatory Breast Neoplasms 1

Interventions

xiapex 7 Microbial Collagenase 7 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Dupuytren Contracture × Surgical Procedures, Operative × Clear all

NCT01444729 2017-10-26

Post Approval Commitment Study

Endo Pharmaceuticals

Dupuytren Contracture

Data powered by HemOnc (CC BY 4.0) Colophon ⚡